Outcomes of glycemic control in type 1 diabetic patients switched from basal insulin glargine 100 U/ml to glargine 300 U/ml in real life

  • Philippe Oriot, Wawrzyniak Jérémie, Martin Buysschaert
  • Expert Review of Endocrinology & Metabolism, May 2018, Taylor & Francis
  • DOI: 10.1080/17446651.2018.1469405

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Philippe Oriot